Starting TRT Dosage: What To Expect In Your First Weeks

Most men starting testosterone replacement therapy (TRT) receive 100 to 200 mg of testosterone cypionate per week, split into two injections. That range comes directly from FDA-approved labeling, which lists 50 to 400 mg every two to four weeks for injectable testosterone cypionate, adjusted based on clinical response (FDA, 2024). But a starting TRT dosage is a hypothesis, not a final answer. The number that goes on the prescription pad depends on lab results, body composition, the formulation chosen, and how an individual patient responds over the first six to eight weeks.

A starting TRT dosage is the initial weekly amount of testosterone prescribed to a man with confirmed testosterone deficiency (hypogonadism), set by a licensed clinician after confirming deficiency through repeated early-morning bloodwork and clinical symptom evaluation, following published guideline criteria.

That definition matters because TRT isn't a fixed protocol. The Endocrine Society's 2018 guideline recommends titrating the dose to bring total testosterone into the mid-normal range while relieving symptoms and avoiding adverse effects (Bhasin et al., 2018). The AUA's guideline echoes this: confirm deficiency with two separate morning draws, then individualize treatment (Mulhall et al., 2018). A starting dose is a calculated guess. Labs at six to eight weeks are the test. This article won't cover bodybuilding-level dosing, peptide protocols, or compounding pharmacy comparisons.

How Do Clinicians Determine a Starting TRT Dosage?

No single number works for every patient. The diagnostic process starts with bloodwork. Both the Endocrine Society and the AUA require at least two total testosterone measurements drawn in the early morning (typically between 8 and 10 AM), on separate days, from the same lab and assay method (Bhasin et al., 2018). The AUA defines testosterone deficiency as a total testosterone consistently below 300 ng/dL, paired with symptoms such as reduced libido, fatigue, erectile dysfunction, or loss of muscle mass (Mulhall et al., 2018). Low lab numbers alone don't qualify. Symptoms must be present.

The pre-treatment panel also includes free testosterone, SHBG (sex hormone-binding globulin), estradiol, hematocrit, PSA (for men over 40), LH, FSH, and a lipid panel. LH and FSH help distinguish primary hypogonadism (testicular failure) from secondary hypogonadism (pituitary or hypothalamic dysfunction). A man with a total testosterone of 180 ng/dL and pronounced symptoms requires a different starting approach than a man at 280 ng/dL with mild fatigue. The clinician weighs all of this, picks a conservative starting dose, and schedules labs for six to eight weeks later.

What Are Common Starting Doses by Formulation?

Starting TRT dosage varies by delivery method. Each formulation carries FDA-approved labeling with its own dosing parameters, and real-world clinical practice often narrows those ranges further.

Injectable Testosterone (Cypionate and Enanthate)

Testosterone cypionate and testosterone enanthate are the most commonly prescribed formulations in the United States. Their half-lives are similar (roughly 8 days for cypionate, 7 to 8 days for enanthate), and dosing is functionally interchangeable (Bhasin et al., 2018). In current clinical practice, most providers start at 100 to 140 mg per week, split into two injections. This split-dose approach may reduce peak-and-trough fluctuations, which some clinicians associate with more stable estradiol levels and mood. Men over 60 or those with elevated baseline hematocrit may start at 75 to 100 mg per week.

Transdermal Gel

Testosterone gel (1% formulation) is typically started at 50 mg applied once daily to the upper arms or shoulders. Absorption varies widely between patients, so labs at six to eight weeks are needed to confirm adequate serum levels. The main clinical concern is transfer risk through skin-to-skin contact.

Testosterone Pellets

Pellets (such as Testopel) are implanted subcutaneously and release testosterone over three to six months. A typical initial implant ranges from 450 to 900 mg total. The dose can't be reduced once pellets are placed, so conservative first-time dosing is standard.

Oral Testosterone (Undecanoate)

Oral testosterone undecanoate (Jatenzo, Kyzatrex, Tlando) was FDA-approved for hypogonadism. The labeled starting dose for Jatenzo is 237 mg twice daily with food. Absorption depends on co-ingestion with adequate fat. Marek Health offers a detailed comparison of oral versus injectable testosterone.

What Factors Shift the Starting Dose Up or Down?

Two men with the same total testosterone reading can require very different starting doses.

SHBG levels. Sex hormone-binding globulin binds testosterone and makes it unavailable for tissue use. A man with SHBG above 50 nmol/L may need a higher starting dose. A man with SHBG below 20 nmol/L may do well at 80 to 100 mg per week with more frequent injections, because low SHBG means more testosterone is already bioavailable.

Body composition. Adipose tissue contains aromatase, the enzyme that converts testosterone to estradiol. Men with higher body fat percentages aromatize more testosterone into estrogen, which can blunt symptom relief. Research has shown an inverse relationship between BMI and testosterone levels (Corona et al., 2013). Heavier men sometimes need a higher starting dose with closer estradiol monitoring.

Age. Men over 60 often respond well to lower doses. SHBG tends to increase with age. Starting at 75 to 100 mg per week and titrating upward is standard for older patients.

Baseline testosterone and symptom severity. A clinician may consider a different starting approach for a man at 150 ng/dL with erectile dysfunction and significant fatigue compared to a man at 280 ng/dL with mild low energy, based on the complete evaluation.

Hematocrit. Testosterone stimulates red blood cell production. The Endocrine Society flags hematocrit above 54% as a point requiring dose reduction or therapeutic phlebotomy (Bhasin et al., 2018). Starting lower and titrating slowly is standard when baseline hematocrit is already elevated.

What Happens During the First 6-8 Weeks on TRT?

A starting dose is not a maintenance dose. The first six to eight weeks are a calibration period. The primary metric is trough total testosterone, drawn just before the next scheduled injection. The Endocrine Society recommends targeting the mid-normal range (Bhasin et al., 2018), which clinicians commonly interpret as a trough somewhere in the mid-normal area, though exact targets vary by provider and patient.

Free testosterone, estradiol (sensitive assay), and hematocrit are checked alongside total testosterone. The Endocrine Society recommends checking hematocrit at three to six months, then annually (Bhasin et al., 2018). A 2011 review found that sexual interest and erectile function may begin improving within three to six weeks, while body composition changes typically require 12 to 16 weeks, and full effects on bone density may take 12 months (Saad et al., 2011). If trough testosterone remains below the target range, the prescribing clinician may increase the dose. If levels run above range or side effects appear, a reduction is typically considered. Changes are incremental and individualized.

How Can Patients Tell Their Dose Needs Adjusting?

Signs the dose may be too low include persistent fatigue, no improvement in libido, and continued brain fog after several weeks on therapy, though these symptoms can have other causes. Lab results and clinical evaluation together guide the decision. Signs the dose may be too high include acne, fluid retention, mood instability, breast tissue tenderness (gynecomastia), elevated hematocrit, and high estradiol. Providers commonly report elevated estradiol from aromatization as a contributing factor in TRT-related side effects. This is why estradiol monitoring matters from the start.

Hematocrit above 54% requires dose reduction or therapeutic phlebotomy (Bhasin et al., 2018; Mulhall et al., 2018). The TRAVERSE trial found testosterone therapy noninferior to placebo for major adverse cardiac events (7.0% versus 7.3%), but also found higher rates of atrial fibrillation (3.5% versus 2.4%) and pulmonary embolism (0.9% versus 0.5%) (Lincoff et al., 2023). The FDA updated class-wide labeling in February 2025, removing prior cardiovascular boxed warning language while adding a new blood pressure warning (FDA, 2025). Blood pressure, hematocrit, and cardiovascular risk factors should be tracked throughout treatment.

Does TRT Affect Fertility?

Exogenous testosterone typically suppresses the hypothalamic-pituitary-gonadal (HPG) axis, which can reduce LH, FSH, and sperm production to varying degrees. The Endocrine Society advises against starting TRT in men planning near-term fertility (Bhasin et al., 2018). The degree of suppression varies, and recovery after discontinuation is not guaranteed. For men who need testosterone support while preserving fertility, clinicians may discuss off-label alternatives such as enclomiphene or hCG, though availability and regulatory status vary. Marek Health has published a detailed comparison of enclomiphene and clomiphene for this purpose.

How Marek Health Approaches Starting TRT Dosage

Testosterone is a Schedule III controlled substance, and all prescriptions require a legitimate medical purpose, clinical evaluation, and lab confirmation. Marek Health is a telehealth provider that prescribes TRT based on lab-confirmed deficiency and evaluation by a licensed clinician. Starting doses follow Endocrine Society and AUA guidelines, with individualization based on each patient's bloodwork, symptoms, body composition, and health history.

The monitoring protocol includes labs at six to eight weeks after initiation, then at three to six months, then annually. Each follow-up includes total and free testosterone, hematocrit, estradiol (sensitive assay), and additional markers as indicated. Marek Health's telehealth model allows patients to complete lab work at a local draw site and consult with a provider remotely. All treatments require evaluation by a licensed provider. Prescriptions are issued only when medically appropriate. Individual results vary.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

What is a typical starting TRT dosage for testosterone cypionate? 

Most clinicians prescribe 100 to 140 mg of testosterone cypionate per week as a starting TRT dosage, split into two injections. FDA labeling lists a broader range of 50 to 400 mg every two to four weeks, but current clinical practice favors lower, more frequent dosing for stable blood levels. The exact starting number depends on baseline testosterone, SHBG, body composition, and symptom severity.

How long does it take to feel the effects of a starting TRT dosage? 

Improvements in sexual interest and erectile function may begin within three to six weeks. Changes in body composition, such as increased lean mass and reduced fat mass, typically require 12 to 16 weeks. Full effects on bone mineral density can take up to 12 months. Individual timelines vary based on starting dose, formulation, and adherence.

Can a starting TRT dosage be too high? 

Yes. Starting too high increases the risk of elevated hematocrit, excess estradiol from aromatization, acne, fluid retention, and mood instability. Clinical guidelines recommend starting conservatively and titrating upward based on six-to-eight-week lab results rather than beginning at the upper end of the dosing range.

What labs are needed before starting TRT? 

The Endocrine Society and AUA require at least two morning total testosterone measurements on separate days, both below the lab's reference range (the AUA uses 300 ng/dL as a threshold). A full pre-treatment panel typically includes free testosterone, SHBG, estradiol, LH, FSH, hematocrit, PSA (for men over 40), and a lipid panel. These labs guide both the diagnosis and the starting dose selection.

Does the starting TRT dosage change based on the delivery method? 

Yes. Injectable testosterone cypionate typically starts at 100 to 140 mg per week. Testosterone gel starts at 50 mg daily. Pellets deliver 450 to 900 mg over three to six months. Oral testosterone undecanoate (Jatenzo) starts at 237 mg twice daily. Each formulation has different absorption characteristics, so the starting dose is formulation-specific.

Will TRT affect fertility? 

Exogenous testosterone suppresses the pituitary signals (LH and FSH) that drive sperm production. The degree of suppression varies between men, and recovery after stopping TRT is variable and not guaranteed. The Endocrine Society recommends against starting TRT in men planning near-term fertility. Alternatives like enclomiphene or hCG may be considered for men who need testosterone support while preserving sperm production.

How often should bloodwork be checked after starting TRT? 

The Endocrine Society recommends checking testosterone and hematocrit at three to six months after starting therapy, then annually once the dose is stable. Most telehealth providers, including Marek Health, check labs at six to eight weeks after initiation to evaluate the starting dose, then again at three to six months, then annually. Additional markers like estradiol, PSA, and lipids are included based on clinical need.

References

• J Clin Endocrinol Metab. 2018;103(5):1715-1744 

• AUA Testosterone Deficiency Guideline. 2018

• N Engl J Med. 2023;389(2):107-117 

• Eur J Endocrinol. 2013;168(6):829-843 

• Eur J Endocrinol. 2011;165(5):675-685 

• FDA Drug Labeling. Testosterone Cypionate Injection, USP. 2024

• FDA Drug Alert. Class-Wide Labeling Changes for Testosterone Products. February 2025